Detalles de la búsqueda
1.
Characterization of Oral Microbiota Following Chemotherapy in Patients With Hematopoietic Malignancies.
Integr Cancer Ther
; 22: 15347354231159309, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-36922730
2.
Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent.
Int Immunopharmacol
; 6(5): 764-73, 2006 May.
Artículo
Inglés
| MEDLINE | ID: mdl-16546707
3.
Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432.
J Natl Cancer Inst
; 95(4): 316-26, 2003 Feb 19.
Artículo
Inglés
| MEDLINE | ID: mdl-12591988
4.
Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Cancer Res
; 64(15): 5461-70, 2004 Aug 01.
Artículo
Inglés
| MEDLINE | ID: mdl-15289356
5.
[The relationship between gene expression of Bcl-2 and Bax and the therapeutic effect in oral cancer patients].
Gan To Kagaku Ryoho
; 33(12): 1723-5, 2006 Nov.
Artículo
Japonés
| MEDLINE | ID: mdl-17212087
6.
[Radiation, 5-FU and OK-432: inhibitory effect of IL-10 and TGF-beta].
Gan To Kagaku Ryoho
; 32(11): 1556-8, 2005 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-16315867
7.
[Anti-tumor immunity induced by OK-432-derived DNA].
Gan To Kagaku Ryoho
; 32(11): 1559-61, 2005 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-16315868
8.
[Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling].
Gan To Kagaku Ryoho
; 32(11): 1562-4, 2005 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-16315869
9.
Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
Anticancer Res
; 22(6A): 3229-39, 2002.
Artículo
Inglés
| MEDLINE | ID: mdl-12530069
10.
[Anti-tumor effect of intratumoral administration of dendritic cells in combination with TS-1 and OK-432].
Gan To Kagaku Ryoho
; 31(11): 1627-30, 2004 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-15553665
11.
[Analysis of the immuno-activation mechanism of OK-432--phagocytosis, release of active components and TLR4 signaling].
Gan To Kagaku Ryoho
; 31(11): 1767-9, 2004 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-15553709
12.
[Anti-cancer effect of an intratumoral injection of dendritic cells expressing TLR4 in combination with an active component of OK-432 in TLR4-deficient mice].
Gan To Kagaku Ryoho
; 31(11): 1770-2, 2004 Oct.
Artículo
Japonés
| MEDLINE | ID: mdl-15553710
13.
Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.
PLoS One
; 9(12): e110378, 2014.
Artículo
Inglés
| MEDLINE | ID: mdl-25461761
14.
Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma.
Neoplasia
; 15(3): 305-14, 2013 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-23479508
15.
Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation.
Neoplasia
; 15(7): 805-14, 2013 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-23814492
16.
Growth inhibition and apoptosis by an active component of OK-432, a streptococcal agent, via Toll-like receptor 4 in human head and neck cancer cell lines.
Oral Oncol
; 48(8): 678-85, 2012 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-22387210
17.
Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
J Immunother
; 29(2): 143-50, 2006.
Artículo
Inglés
| MEDLINE | ID: mdl-16531815
18.
Mechanism of anticancer host response induced by OK-432, a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling.
J Immunother
; 29(1): 78-86, 2006.
Artículo
Inglés
| MEDLINE | ID: mdl-16365603
19.
TX-1877, a bifunctional hypoxic cell radiosensitizer, enhances anticancer host response: immune cell migration and nitric oxide production.
Int J Cancer
; 116(4): 571-8, 2005 Sep 10.
Artículo
Inglés
| MEDLINE | ID: mdl-15825172
20.
Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.
J Immunother
; 27(6): 432-41, 2004.
Artículo
Inglés
| MEDLINE | ID: mdl-15534487